Status | Study |
Active, not recruiting |
Study Name: Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Condition: Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Date: 2010-10-07 Interventions: Biological: Bevacizumab Given |
Completed |
Study Name: RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma Condition: Acoustic Schwannoma Adult Anaplastic (Malignant) Meningioma Date: 2010-05-06 Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy |
Terminated |
Study Name: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-03-16 Interventions: Drug: gamma-secretase/Notch signalling pathway inhibitor RO4929097 |
Completed |
Study Name: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Choriocarcinoma Date: 2010-02-25 Interventions: Drug: vorinostat Other Names: |
Active, not recruiting |
Study Name: Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma Condition: Brain Tumor Medulloblastoma Pineobla Date: 2010-02-03 Interventions: Radiation: proton beam radiation Given once a day, 5 days a week (Monday-Friday) |
Completed |
Study Name: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condition: Childhood Burkitt Lymphoma Childhood Central Nervous System Choriocarcinoma Date: 2009-10-10 Interventions: Drug: vorinostat Given orally |
Recruiting |
Study Name: Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors Condition: Adult Central Nervous System Germ Cell Tumor Adult Ependymoblastoma Date: 2009-09-23 Interventions: Drug: Carboplatin Given IA |
Completed |
Study Name: ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors Condition: Childhood Atypical Teratoid/Rhabdoid Tumor Childhood Central Nervous System Germ Cell Tumor Date: 2009-07-24 Interventions: Drug: veliparib Given PO |
Active, not recruiting |
Study Name: Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Condition: Untreated Childhood Medulloblastoma Untreated Childhood Pineoblastoma Date: 2009-03-20 Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy |
Active, not recruiting |
Study Name: Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor Condition: Solid Tumor Adult Central Nervous System Germ Cell Tumor A Date: 2008-03-18 Interventions: Drug: busulfan Given IV |